Change of Adviser

RNS Number : 2799V

Port Erin Biopharma Investments Ltd

15 April 2016

 

Port Erin Biopharma Investments Limited

("Port Erin" or the "Company")

Change of Adviser

The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the appointment of Northland Capital Partners Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.

Enquiries     

Port Erin Biopharma Investments Limited	[phone]
Denham Eke
Northland Capital Partners Limited	[phone]
Nominated Adviser and Joint Broker
Matthew Johnson / David Hignell / Gerry Beaney (Corporate Finance)
John Howes / Rob Rees (Broking)
Peterhouse Corporate Finance Limited	[phone]
Joint Broker
Lucy Williams

 

END

 

 

APPBLGDSBXBBGLS